Dr Peter Jones from Houston Methodist Hospital discusses cardiovascular disease and lipids, topics in which he is speaking about during Consultant360's Cardiometbolic Risk Summit this year.

In this podcast, Dr James Januzzi from Massachusetts General Hospital discusses the new consensus statement on heart failure, biomarker testing for diagnosing and managing heart failure, and current trials for potential future treatments of heart failure.

In this podcast, Dr James Januzzi from Massachusetts General Hospital discusses the new consensus statement on heart failure, biomarker testing for diagnosing and managing heart failure, and current trials for potential future treatments of heart failure.

Dr Annette Langer-Gould is a neurologist, multiple sclerosis specialist, and the regional lead for clinical and translational neuroscience at Kaiser Permanente Southern California, and is a member of the American Academy of Neurology. In this podcast, she discusses her research on the effect of fish oil on multiple sclerosis risk.

Dr Annette Langer-Gould is a neurologist, multiple sclerosis specialist, and the regional lead for clinical and translational neuroscience at Kaiser Permanente Southern California, and is a member of the American Academy of Neurology. In this podcast, she discusses her research on the effect of fish oil on multiple sclerosis risk.

Dr Jamie Koufman, founder and director of the Voice Institute of New York and one of the world's leading authorities on acid reflux, discusses proton pump inhibitors—their adverse effects, alternatives, and more.

Dr Jamie Koufman, founder and director of the Voice Institute of New York and one of the world's leading authorities on acid reflux, discusses proton pump inhibitors—their adverse effects, alternatives, and more.

Dr Pavan Bhargava, who is an assistant professor of Neurology at Johns Hopkins University, explains what multiple sclerosis is and how it is diagnosed in the clinic.

Dr Pavan Bhargava, who is an assistant professor of Neurology at Johns Hopkins University, explains what multiple sclerosis is and how it is diagnosed in the clinic.

Dr Thomas Seck, who is the vice president of Clinical Development and Medical Affairs at Boehringer Ingelheim Pharmaceuticals, discusses the EMPERIAL trials, which aim to expand the use of empagliflozin for heart failure.